Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-06-28

Clinical Trial Update: A Study of AND017 to Treat Anemia in Chronic Kidney Disease Patients on Dialysis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating AND017 for treating anemia in chronic kidney disease patients on dialysis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AND017

Snippet

Sponsor: Kind Pharmaceuticals LLC | Conditions: Renal Anemia | Phase 2 | Status: COMPLETED